Skip to main content
. 2022 Apr 27;15:874903. doi: 10.3389/fnmol.2022.874903

TABLE 1.

Baseline characteristics of study participants.

Parameter HCs IS (11–72 h) p values*
Age and gender
Total, n 33 40
Male, n (%) 18 (55) 18 (45) 0.417
Age (y), mean (SD) 63.67 (8.9) 68.1 (11.9) 0.0813
Stroke risk factors, n (%)
Hypertension 17 (51.5) 22 (55) 0.733
Diabetes mellitus 5 (15.2) 8 (20) 0.590
Hyerlipidaemia 6 (18.2) 9 (22.5) 0.594
Smoker 4 (12.1) 5 (12.5) 0.497
History of stroke/TIA 2 (6) 6 (15) 0.058
Laboratory parameters, mean ± SD
Glucose, mmol/L 6.57 ± 1.73 7.14 ± 2.08 0.2133
Platelets, 109/L 210.9 ± 41.06 191.6 ± 55.7 0.1027
Triglycerides, mmol/L 1.19 ± 0.60 1.22 ± 0.88 0.8683
Total cholesterol, mmol/L 4.66 ± 0.82 4.35 ± 0.99 0.1551
HDL, mmol/L 1.33 ± 0.27 1.24 ± 0.37 0.2482
LDL, mmol/L 2.68 ± 0.54 2.46 ± 0.73 0.1553
WBC count, 109/L 5.85 ± 0.96 6.7 ± 2.69 0.0889
RBC count, 1012/L 4.71 ± 0.43 4.52 ± 0.47 0.0784
NIHSS score <0.01
Mean (25th–75th percentile) 0 (0) 10 (6.75-14)
Infarct volume
Mean (25th–75th percentile), mL n/a 12.70 (3.04-25.87) <0.01

*For Continuous variables, a Wilcoxon test was used to assess differences, while for categorical variables, a Fisher’s exact test was used.

HDL, high-density lipoprotein; LDL, low-density lipoprotein; n/a, not available, RBC, red blood cell; TIA, transient ischemic attack; WBC, white blood cell.